Posttransplant Cyclophosphamide for HLA-haploidentical Transplantation in Patients With Mucopolysaccharidosis. [electronic resource]
Producer: 20190318Description: e350-e354 p. digitalISSN:- 1536-3678
- Allografts
- Antilymphocyte Serum -- administration & dosage
- Busulfan -- administration & dosage
- Child, Preschool
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Female
- Follow-Up Studies
- Graft vs Host Disease -- mortality
- HLA Antigens
- Hematopoietic Stem Cell Transplantation
- Humans
- Infant
- Male
- Mucopolysaccharidoses -- mortality
- Survival Rate
- Transplantation Conditioning
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.